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ABSTRACT  The binding of platelets  to components  in the subendothelial  matrix  is an  initial 
event in hemostasis  and thrombosis.  The glycoprotein  components of the matrix are consid- 
ered important in this interaction. Of these, collagen binds and activates  platelets  and induces 
their aggregation.  In this study we demonstrate that substrate-bound laminin causes time- and 
concentration-dependent  adherence  of  human  platelets  to  the  substrate.  The  binding  of 
platelets to laminin was found to be similar in some respects,  but different  in others, to their 
binding to surfaces coated with fibronectin or collagen. The binding of platelets  to laminin or 
fibronectin was not associated  with their activation  under conditions in which type I collagen 
activates  the platelets as measured by [14C]serotonin  secretion. Platelets bound to laminin and 
fibronectin  differed  in  their appearance;  they  remained  rounded  on  laminin  whereas they 
flattened  completely  on  fibronectin.  Binding  of platelets  to  fibronectin,  but  not  laminin,  is 
inhibited  by a recently described  peptide (Pierschbacher,  M., and E. Ruoslahti,  1984, Nature 
(Lond.),  309:30-33) containing the cell-attachment tetrapeptide sequence of fibronectin, which 
suggests that  separate  receptors  exist  for  laminin  and  fibronectin.  These  studies  establish 
laminin as a platelet-binding  protein and suggest that laminin can contribute to the adhesive- 
ness of exposed  tissue  matrices  to  platelets.  Since  laminin  and  fibronectin  do  not activate 
platelets,  whereas collagen does, and laminin differs from fibronectin in that it does not induce 
spreading of the attached platelets,  all three proteins appear to confer different signals to the 
platelets.  Some  of these may be related to platelet functions  other than those necessary  for 
the formation of a hemostatic plug. 
The  vascular  endothelium  in  vivo  is  a  nonthrombogenic 
entity. This property stems from inability of the endothelial 
cell apical surface to bind platelets. In vitro cultures of  vascular 
endothelium are also nonthrombogenic if they are maintained 
under conditions that support their normal contact-inhibited, 
nonoverlapping monolayer configuration (1-3). If, however, 
the  cell  layer  is  removed,  the  platelets  can  adhere  to  the 
underlying extracellular matrix which resembles a basement 
membrane (4). Exposure of the subendothelial matrix in vivo 
also leads  to platelet  attachment  (5) and  this  phenomenon 
has been suggested to play a role in the etiology of atheroscle- 
rosis (6). 
Extracellular matrices contain proteins known to be adhe- 
sive  to  platelets.  For  example,  the  binding  of platelets  to 
various types of collagen (7-9) and  to fibronectin  (10)  has 
been reported.  Endothelial  and other basement membranes 
also contain laminin,  which like fibronectin is a large glyco- 
protein adhesive to various types of nucleated cells (11-13). 
Whether insolubilized laminin also interacts with platelets has 
not been studied previously. The potential importance of  such 
an  interaction  as  a  component of the  platelet-extracellular 
matrix  interactions  has  led  us  to  study  the  adherence  of 
platelets to surfaces coated with purified laminin. 
We show here that platelets bind to laminin-coated surfaces. 
Comparison  of this  binding  to  the  binding  of platelets  to 
fibronectin- and type I collagen-coated surfaces indicates that 
beyond binding,  each of these matrix  proteins has different 
effects on platelets with regard to spreading, aggregation, and 
activation of the platelets. 
MATERIALS  AND  METHODS 
Isolation and Labeling of Platelets:  Human  blood (60 ml) was 
collected on the day of the experiment in polypropylene  tubes containing  5 ml 
of anticoagulant solution (2.5% sodium citrate, 1.4% citric acid, and 2% 
dextrose, pH 4.6). Donors were females who had not ingested aspirin for at 
least 10 d prior  to collection.  Platelets were isolated by differential centrifugation 
and gel filtration  on S~pharose 2B (Pharmacia  Fine Chemicals,  Piscataway,  N J) 
(14). The isolated platelets were labeled with either [~4C]serotonin  (2 uCi/ml of 
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50.7 mCi/mmol) or 5 ,Ci/ml of Na2[~Cr]O,  in sterile saline (New England 
Nuclear, Boston, MA), by incubation  in a 37"C water bath for 1 h before gel 
filtration. The average yield of  platelets from 60 ml of  blood was approximately 
5  x  109, and  [J4C]serotonin or Na2[StCr]O4 labeling averaged  103  cpm/10  ~ 
platelets. 
Proteins and Coating Procedures:  Laminin  was  prepared  as 
described from rat (15) or mouse (16) tumors.  Large fragments of human 
laminin were isolated from pepsin extracts of placenta using affinity chroma- 
tography on monoclonal antibody (17). Fibronectin was prepared from human 
plasma (18). Type I collagen was from the Collagen Corp. (Palo Alto, CA), and 
BSA and thrombin were from Sigma Chemical Co. (St. Louis, MO). Synthetic 
peptides were from Peninsula  Laboratories,  Inc. (Belmont, CA). Protein con- 
centrations  were determined  by Coomassie Blue binding assay (19) using BSA 
as standard, except for collagen which was determined by the method of Lowry 
et al. (20) using type I collagen as a standard.  Coating of 35-mm petri dishes 
(Falcon,  LabWare, Div. of Becton Dickinson  & Co., Oxnard,  CA) with the 
various proteins was carried out overnight at 4"C or for 1-2 h at 37°C in 1 ml 
of PBS at the concentrations  indicated  in the figure legends. The coating was 
followed by washing and further incubation  of the dishes with PBS containing 
0.5% BSA to prevent any nonspecific platelet adherence to the plastic. 
Binding/Secretion  Assays:  In a typical binding assay, 0.5-2 x  l0  s 
platelets  labeled  with  [~4C]serotonin or Na2[5~Cr]O4 in  1 ml of Dulbecco's 
modified Eagle's medium (DME) ~  containing 0.5% BSA were plated onto the 
various protein-coated  petri dishes. Incubations at 37°C in a humidified incu- 
bator were varied between 30 rain and 4 h. At~er incubation,  the media with 
nonbound platelets were collected. For Na2[~Cr]O~-labeled platelets, radioac- 
tivity  in  the  platelets  bound to the  dishes  was determined  after  extensive 
washing. For [~4C]serotonin-labeled  platelets, the radioactivity of  three fractions 
was determined;  i.e., radioactivity  associated  with  the bound platelets  after 
washing, that found in the supernatant after removal of the nonbound platelets 
by centrifugation, and that associated with the nonbound platelets. 
Antibodiesflnhibition  Assay:  Goat anti-rat  laminin  antibodies 
were affinity purified on laminin-Sepharose as described (17). Affinity-purified 
goat antibodies to human alpha-fetoprotein  (21) were used as a control.  The 
affinity-purified antibodies  were incubated  on coated  dishes for 2 b at 37"C 
before the addition  of platelets. 
Scanning Electron Microscopy:  12-mm circular  glass coverslips 
were coated with laminin  or fibronectin as described above. Platelets (2 x  10  ~) 
JAbbreviation used in this paper.  DME, Dulbecco's modified Eagle's 
medium. 
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hGURE  1  Binding and activation of 
human  platelets on  surfaces  coated 
with  extracellular  matrix  compo- 
nents. Petri dishes were coated with 
rat laminin (30 ug/ml), fibronectin (10 
~g/ml), or type I collagen (50/~g/ml) 
as described  in Materials and Meth- 
ods.  Dishes coated with  BSA (5  rag/ 
ml)  were  used  as  controls.  Human 
platelets labeled with  [14C]serotonin 
(1  x  10  a platelets, 1.5 x  105 cpm) in 
1  ml  of  DME  supplemented  with 
0.5%  BSA  were  added  to  these 
dishes and  incubated  for  90  min  at 
37"C. Thrombin was added to some 
dishes  at  a  final  concentration  of  1 
U/ml.  The  media  with  nonbound 
platelets were collected  and  centri- 
fuged. The dishes with bound plate- 
lets  were  washed  extensively with 
PBS that contained 0.5% BSA.  [14C]- 
Serotonin  radioactivity  was  then 
measured and values were expressed 
as [14C]serotonin in the bound (B) or 
cell-free media (M) fractions. The ra- 
dioactivity not present  in  these two 
fractions was recovered in the  non- 
bound  platelet fraction which  is not 
shown. 
were incubated  on these coverslips in Dulbecco's  modified  Eagle's medium 
containing 0.5% BSA. Unbound platelets were washed away and bound plate- 
lets were fixed in 2.5% glutaraldehyde,  postfixed in 2% OsO4, and dried  by 
Freon to liquid CO2 substitution in a Polaron 3000 critical-point dryer (Polaron 
Instruments Inc., Hatfield, PA). Coverslips were coated using a gold-palladium 
(80:20) source in an E5100 Polaron sputter coater and viewed with an Hitachi 
H-600 electron microscope. 
RESULTS 
Binding and Activation of Platelets on Surfaces 
Coated with Extracellular Matrix Components 
Binding  of platelets  to  dishes  coated with  laminin  was 
observed visually and by quantitation of [~4C]serotonin in the 
bound platelets (Fig.  1). No significant release of [~4C]sero- 
tonin into the media, which would have been indicative of 
activation,  occurred on  laminin.  Binding  of platelets also 
occurred on dishes coated with fibronectin as has been ob- 
served  earlier (10,  22).  However, twice  as  many platelets 
bound to laminin-coated than to fibronectin-coated dishes, 
reflecting the  fact that  the  platelets  on  laminin  remained 
rounded, whereas those on fibronectin were completely fiat- 
tened (see Fig.  3). Controls showed that no binding or acti- 
vation of the platelets took place on BSA-coated substrates, 
i.e., all the [~4C]serotonin was found in the nonbound plate- 
lets. When thrombin was added, all of the radioactivity was 
released into the media. On dishes coated with collagen, the 
platelets bound to the substrate, but their ['4C]serotonin was 
released into the media, indicating activation. Only the plate- 
lets  that  had  bound  to  the  coated surface were activated, 
however, as nonbound platelets retained their [~4C]serotonin 
(not shown). 
The degree of platelet binding to laminin and fibronectin 
was dependent on the concentration of the coating protein. 
Increased  concentrations of laminin  or fibronectin coated 
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sured by binding of radioactivity from platelet suspensions 
labeled with  [14C]serotonin  or Na2[5'Cr]O4  (Fig.  2).  Similar 
results were obtained with rat and mouse laminin and with 
the peptic fragments of human laminin. 
Since the binding of platelets to laminin or fibronectin was 
always fractional, it was necessary to address the question of 
whether different subpopulations of platelets were binding to 
the two proteins. This was studied by the transfer experiment 
shown in Table I. After platelets were incubated on laminin- 
coated dishes,  the  platelets that  remained  nonbound  were 
transferred to a second set of laminin-coated dishes. A similar 
percentage of platelets bound to the first and second series of 
dishes,  suggesting that  no depletion  of a  putative laminin- 
binding subpopulation had occurred in the first incubation. 
When  the  platelets that  remained  nonbound  through  two 
cycles of attachment to laminin were transferred to fibronec- 
tin-coated dishes, the percentage that attached was similar to 
that from the original platelet suspension, indicating no sig- 
nificant enrichment of a  fibronectin-binding population.  A 
reciprocal experiment in which the first two incubations were 
on fibronectin also Showed no evidence of separation of the 
platelets into subpopulations. These results suggest that the 
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FIGURE  2  Platelet binding to substrates coated with different con- 
centrations of laminin or fibronectin. Petri dishes were coated with 
increasing concentrations (I .0-I 00 ~.g/ml) of either human laminin 
or  human  fibronectin.  Human  platelets  (2  x  10  a)  labeled  with 
Na2[S~Cr]O4 in  1 ml  of  DME  supplemented with  0.5%  BSA were 
incubated for 45 min at 37"C. The media with nonbound platelets 
were removed and any nonbound platelets remaining in the dish 
were washed away with PBS that contained 0.5% BSA. 
capacity of platelets to bind to fibronectin or to laminin  is 
not a characteristic of specific subpopulations of platelets. 
Morphology of Platelets Attached to Different 
Surfaces 
Scanning  electron  microscopy  showed  that  platelets  re- 
mained rounded when attached to laminin whereas attach- 
ment to fibronectin was associated with complete flattening 
(Fig.  3,  b vs.  a).  No evidence of lysis or aggregation of the 
bound platelets was seen on laminin or fibronectin, in agree- 
ment with the lack of activation demonstrated by the [~4C]- 
serotonin release measurements. 
Lack of Platelet Activation upon Prolonged 
Contact with Laminin 
To  determine  whether  activation as  measured  by  [~4C]- 
serotonin secretion might occur over a prolonged incubation 
of platelets on  laminin, we carried out time-course experi- 
ments. No [~4C]serotonin  was released into the media over a 
3-h incubation when platelets were incubated on laminin (Fig. 
4) or fibronectin-coated (data not shown) substrates. In con- 
trast, on type I collagen-coated substrate, [~4C]serotonin  was 
continually secreted and was completely released by 3 h (Fig. 
4). 
To investigate whether activation was a function of platelet 
density,  we  incubated  increasing  concentrations  of plate- 
lets on laminin-coated substrates. There was no secretion of 
[~4C]serotonin by platelets on laminin substrates at any plate- 
let  density.  On  collagen-coated  substrates,  the  release  of 
['4C]serotonin into the media increased in proportion to the 
number of platelets present (data not shown). These results 
suggest that binding of platelets to laminin (or fibronectin) is 
not associated with secretion of [14C]serotonin  either tempo- 
rally or as a function of platelet density. 
Differential Inhibition of Binding of Platelets to 
Laminin and Fibronectin 
Recent studies from this laboratory have demonstrated that 
fibroblasts  adhere  to  fibronectin  through  the  amino  acid 
sequence  arginine-glycine-aspartic acid-serine  contained  in 
the cell attachment domain of fibronectin and that the attach- 
ment of cells to fibronectin-coated substrates can be inhibited 
by micromolar quantities of synthetic peptides containing this 
sequence (23). Since a number of other proteins that interact 
with cell surfaces share this sequence (23), the peptides offered 
a useful probe for the analysis of the mechanism of platelet 
adherence to various substrates. When equimolar amounts (5 
x  10  -8 M) of laminin and fibronectin were used to coat petri 
dishes, and platelets were incubated in media with a peptide 
TABLE  I 
Binding of Platelets upon Repeated Incubation on Laminin- or Fibronectin-coated Dishes 
After 2 incubations on  After 2 incubations on 
First incubation  Second incubation  fibronectin  laminin 
On laminin  17 _  0.2  17.5 ___ 0.1  17.9 +_ 2.2  -- 
On fibronectin  7.5 +_ 0.7  6.5 _  0.4  --  8.0 _  0.3 
Platelets  were isolated  and labeled with [14C]serotonin  to 10,000 cpm/1.8 x  107 platelets.  Petri  dishes  were coated with laminin or fibronectin  (30/~glmI) as 
described  in  Materials and  Methods, and  2 ×  108 platelets  were added to them  in the initial  incubation.  Each incubation  was for 45 min  in  2 ml  of DME 
supplemented with 0.5% BSA at 370C. The unbound platelets  were then transferred to another dish as indicated. Each transfer  was done in triplicate and data 
are expressed as percentage of attached cells (mean  -  SE). 
2142  THE JOURNAL OF  CELL BIOLOGY - VOLUME 99, 1984 FIGURE  3  Scanning electron microscopy of platelets bound to laminin or fibronectin.  Laminin and fibronectin (50 #g/ml) were 
coated onto glass coverslips as described in Materials and Methods. The platelets (2 x  108) were incubated on the coated surfaces 
for  1  h  at 37"C  in  1 ml of  DME  supplemented with  0.5%  BSA. At the end of this  incubation, the  coverslips were fixed and 
examined by scanning electron microscopy. Platelets bound to fibronectin (a) (x 5,000) or to laminin (b) (x 2,000). 
containing the arg-gly-asp-ser sequence, the binding of plate- 
lets to fibronectin was inhibited in a dose-dependent fashion, 
whereas their attachment to laminin was unaffected (Fig.  5). 
A  control  peptide,  gly-asp-ser-pro, previously shown  to  be 
inactive in the adhesion offibroblasts, had no inhibitory effect 
on platelet binding to either fibronectin or laminin.  Similar 
results were obtained with another inactive peptide, arg-val- 
asp-ser-pro-ala-cys  (results not shown). Neither of  the peptides 
at the concentrations indicated caused platelet activation as 
measured by secretion of [~4C]serotonin  into the media. That 
the binding of platelets to laminin could be specifically inhib- 
ited with an  appropriate reagent was shown  using affinity- 
purified laminin antibodies,  which  inhibited the binding of 
platelets to dishes coated with laminin (Table II). Attempts to 
show reciprocal inhibition  with fibronectin antibodies were 
not successful because fibronectin-coated dishes treated with 
antifibronectin tended to activate the platelets (not shown). 
DISCUSSION 
The studies presented here identify laminin as a new adhesive 
protein  for  platelets.  The  specificity  of the  interaction  of 
laminin with platelets is supported by several observations. 
First,  the  binding  was  dependent  on  the  concentration  of 
laminin and reached a  level 20 times higher than the back- 
ground  binding  observed  on  dishes  coated  with  albumin. 
Second,  this effect was obtained with laminin  preparations 
purified  from  three  different  species.  These  laminins were 
purified using different methods, affinity chromatography on 
monoclonal antibodies was used for human laminin, and salt 
fractionations and  heparin-Sepharose affinity chromatogra- 
phy were used for the rodent laminins.  Thus, the effect on 
platelets is likely to be inherent to the laminin molecule and 
not caused by a contaminant. Furthermore, the adhesion of 
platelets to laminin showed characteristics fundamentally dif- 
ferent from those observed on fibronectin or collagen. 
Adhesion of platelets to laminin was distinct in that it was 
not associated with the spreading observed on fibronectin or 
with  the  activation that  took place  on  type I  collagen.  In 
addition, antilaminin antibodies inhibited binding of platelets 
to  laminin,  while  a  soluble  cell  attachment  peptide  from 
fibronectin inhibited  the  binding  of platelets to  fibronectin 
but not to laminin. These observations suggest  the existence 
of different cellular receptors for fibronectin and laminin on 
platelets, and that adhesion ofplatelets through these receptors 
results in  different responses. That laminin and fibronectin 
would differ with regard to the cellular response they elicit is 
not  without precedent.  Neuronal  cells form neurites in  re- 
sponse to adherence to laminin, but they respond much less 
to fibronectin (24, 25). 
Our data demonstrate that the binding of platelets to lam- 
inin is not accompanied by their activation as shown by the 
lack of release of serotonin from the platelets and their intact 
appearance in scanning electron microscopy after binding to 
laminin-coated  surface.  These  data  similarly  confirm  that 
platelets attach and spread on fibronectin (10,  22),  but they 
also show that activation as measured by ['4C]serotonin re- 
lease does not occur. 
In contrast to laminin and fibronectin, type IV collagen of 
basement membranes, like type I collagen, has been shown 
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FIGURE  4  Time course of platelet bind- 
ing and secretion on laminin- or Type I 
collagen-coated substrates. Petri dishes 
were coated with either 30 #glml lami- 
nin or 50/~glml type I collagen. Human 
platelets  (I  x  108) labeled  with  [14C]- 
serotonin were added to these dishes in 
I  ml of DME  supplemented with 0.5% 
BSA.  Duplicate dishes at the  indicated 
times were collected and processed as 
described  in  Materials  and  Methods. 
Data are presented as [14C]serotonin in 
the bound (O), media (I-I), or nonbound 
(A) fractions. 
FIGURE  5  Inhibition of platelet binding 
to fibronectin and laminin by synthetic 
peptides. Petri dishes were coated with 
40/~glml of laminin or 20 #gJml of fibro- 
nectin. Human platelets (I x  108) labeled 
with [14C]serotonin were added to these 
dishes with and without increasing con- 
centrations of either g]y-arg-gly-asp-ser- 
pro (I) or gly-asp-ser-pro (C)  in  I  ml of 
DME supplemented with 0,5% BSA. The 
dishes were then incubated I  h at 37°C. 
Data  represent radioactivity associated 
with the bound platelet fraction. TABtE  II 
Inhibition of Platelet Binding to Laminin by Antibodies 
Substrate  Condition  Bound  platelets 
% 
Laminin  Control  100 ___ 9.6 
Laminin  +  Antilaminin  8.4 4- 0.3 
Laminin  +  Control antibody  84 4- 0.7 
Petri dishes were coated with l0 #g]ml of rat laminin.  After incubation with 
antibodies (10/,tg/ml),  the dishes were washed and  1 x  10  a [14C]serotonin- 
labeled  human  platelets  were added  in  1 ml of DME  supplemented  with 
0.5% BSA. Incubation  time was  1 h at 37"C.  Bound  platelets  and  media 
[14C]serotonin  were determined  as  described  in  Materials and  Methods. 
[~4C]Serotonin secreted into the media by platelets on laminin-coated dishes 
was <7% of the total counts added, indicating a lack of activation. No further 
secretion was measured  on  antibody-coated  laminin  substrates.  Triplicate 
determinations were made and data are expressed  as the mean +  SE. 
to be capable of activating platelets (7). Basement membrane- 
like endothelial cell matrices formed in vitro also bind plate- 
lets but appear not to activate them (2, 26, 27). Since laminin 
and fibronectin, unlike collagen, do not activate platelets, they 
may be the molecules to which platelets attach in a basement 
membrane  in  this  situation.  It  is  also  possible  that  these 
glycoproteins modify the response of platelets to collagen in 
an extracellular matrix. It has been reported that binding of 
fibronectin to collagen suppresses the platelet-aggregating ac- 
tivity of collagen (28).  Laminin might play a similar role in 
basement membranes. However, further data will be needed 
to determine whether the platelet-laminin interaction could 
occur in vivo. For instance, whether plasma proteins could 
affect  the  interaction  remains  to  be  studied.  Our  binding 
assays were carried out by using platelets separated from the 
plasma because divalent cations, which have previously been 
reported  to  be  essential  for  the  binding  of fibronectin  to 
platelets  (29),  had  been  removed  from  the  plasma by  the 
anticoagulant. 
The lack of activation of the thrombogenic responses by 
platelets attaching to noncollagenous adhesive proteins and 
basement membranes suggests that such binding may serve 
purposes other than hemostasis. Under some circumstances 
alpha-granule proteins such as platelet-derived growth factor 
might be released without the release of serotonin from the 
dense granules (30).  It will be interesting to know whether 
binding  of platelets  to laminin and fibronectin  might be a 
sufficient stimulus to enable platelets to play a role in endo- 
thelial cell  proliferation over an area of exposed  basement 
membrane. 
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